Shao, W., Kuhn, C., Mayr, D., Ditsch, N., Kailuwait, M., Wolf, V., . . . Sixou, S. (2020). Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers. J Transl Med.
Chicago-stil citatShao, Wanting, et al. "Cytoplasmic PPARγ Is a Marker of Poor Prognosis in Patients With Cox-1 Negative Primary Breast Cancers." J Transl Med 2020.
MLA-referensShao, Wanting, et al. "Cytoplasmic PPARγ Is a Marker of Poor Prognosis in Patients With Cox-1 Negative Primary Breast Cancers." J Transl Med 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.